Caption Management, LLC Ab Cellera Biologics Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $788,717 - $1.21 Million	83,198 Added 1620.53%	88,332 $894,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $47,232 - $70,233	5,134 New	5,134 $51,000
Q4 2021 Feb 11, 2022	BUY	$12.99 - $17.73 $827,463 - $1.13 Million	63,700 Added 910.0%	70,700 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$14.85 - $21.34 $102,465 - $147,246	6,900 Added 6900.0%	7,000 $140,000
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $2,019 - $3,417	100 New	100 $2,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.